Offer DescriptionWe announce a 2.5-year Postdoctoral Fellow position in Computational Biology & Gene Regulation position (SKO1352) in the (NCMM) & (FIMM) laboratories as part of the program. The work focuses on building a gene editing platform that can be used to correct patient-specific mutations in ex vivo cell therapies for monogenic immune diseases. We use high-throughput biology techniques to optimize, develop and understand the CRISPR-Cas9 system that forms the base of the platform, and develop and implement methods to evaluate its safety in a clinical setting. We will use the gene editing technologies for the benefit of the patients in the Nordic hospitals.is a collaborative postdoctoral program of the . The partnership is a network of four national research centers across the Nordics and the , with complementary research expertise at the forefront of molecular medicine research. With the NORPOD program, the Nordic EMBL Partnership aims to foster the next generation of researchers in molecular medicine by implementing joint postdoctoral research projects to nurture strong competences and research excellence. To promote collaboration between the two labs, the successful candidate is expected to travel between the labs in Norway and Finland to conduct work required for the research project to foster synergies.For more information and how to apply:RequirementsResearch Field Medical sciences Education Level PhD or equivalentAdditional InformationWork Location(s)Number of offers available 1 Company/Institute Centre for Molecular Medicine Norway (NCMM) Country Norway GeofieldWhere to apply WebsiteContact CityOslo WebsiteStreetPO box 1072 Blindern Postal CodeNO-0316 E-Mailemma.haapaniemi@ncmm.uio.noSTATUS: EXPIRED